Braze Mobility: Mobilizing Plans for Growth Custom Case Solution & Analysis

Evidence Brief: Case Extraction

Financial Metrics

• Product Pricing: The Sentina system retails between 1500 and 2500 USD depending on the sensor configuration.
• Market Size: Approximately 75 million people globally require wheelchairs for mobility.
• Market Value: The global power wheelchair market is valued at approximately 2.5 billion USD with a 7 percent annual growth rate.
• Damage Costs: Wheelchair accidents result in property damage and personal injury costs exceeding tens of thousands of dollars per major incident for long-term care facilities.
• Funding: The company successfully secured initial seed funding and government grants for research and development.

Operational Facts

• Product Technology: Uses ultrasonic sensors to provide spatial awareness through haptic, visual, and audio feedback.
• Installation: Designed as an after-market add-on compatible with most major manual and power wheelchair brands.
• Manufacturing: Assembly and quality control are centralized to maintain medical-grade standards.
• Regulatory Status: Classified as a Class I medical device in multiple jurisdictions including Canada and the United States.
• Sales Channels: Current distribution involves a mix of direct sales to institutions and partnerships with specialized medical equipment providers.

Stakeholder Positions

• Dr. Pooja Viswanathan: Founder and CEO; advocates for a balance between clinical impact and commercial viability.
• Occupational Therapists (OTs): Act as primary gatekeepers; their recommendation is essential for product adoption and insurance reimbursement.
• The Veterans Affairs (VA) Department: Represents the largest potential institutional buyer in the United States; focused on veteran safety and cost reduction.
• Wheelchair OEMs: Original Equipment Manufacturers who represent both potential partners for integration and future competitive threats.

Information Gaps

• Cost of Goods Sold (COGS): The case does not explicitly detail the unit-level manufacturing cost or gross margin percentages.
• Customer Acquisition Cost (CAC): Specific marketing and sales spend required to convert a single institutional lead is not provided.
• Reimbursement Codes: The specific status of HCPCS codes for the Sentina system in the US market is not finalized in the text.

Strategic Analysis

Core Strategic Question

• How can Braze Mobility transition from a niche research-driven startup to a scalable commercial entity while managing limited capital?
• Should the company prioritize the high-volume but high-friction US Veterans Affairs (VA) channel or pursue a broad international distributor model?

Structural Analysis

The medical assistive technology market is defined by high buyer power and significant regulatory barriers. Using the Value Chain lens, the primary bottleneck for Braze Mobility is not product development but outbound logistics and sales. The bargaining power of insurers and government payers like the VA determines the ceiling for pricing. Currently, the company operates with a fragmented sales approach that dilutes its limited resources across too many geographies.

Strategic Options

Option 1: US Institutional Focus (The VA Strategy)

• Rationale: Focus all sales efforts on the US Department of Veterans Affairs. It is the largest single purchaser of wheelchairs in the world.
• Trade-offs: High concentration risk; long sales cycles (12 to 18 months); requires significant clinical documentation.
• Resource Requirements: Dedicated US-based clinical sales team and investment in regulatory compliance.

Option 2: Global Distributor Model

• Rationale: Partner with existing medical equipment distributors in Europe and Asia to minimize direct sales overhead.
• Trade-offs: Lower margins due to distributor cuts; loss of direct customer feedback; brand dilution.
• Resource Requirements: International channel manager and localized marketing collateral.

Option 3: OEM Integration Partnership

• Rationale: License the technology to major wheelchair manufacturers to be included as a factory-installed feature.
• Trade-offs: Loss of after-market revenue; long engineering integration timelines; risk of intellectual property theft.
• Resource Requirements: Technical integration engineers and legal counsel for licensing agreements.

Preliminary Recommendation

Braze Mobility should adopt Option 1. The US VA market provides the highest density of target users and a centralized procurement process. Securing the VA as a primary client creates a clinical gold standard that will later simplify entry into private insurance markets. This path prioritizes cash flow stability over geographic breadth.

Operations and Implementation Planner

Critical Path

The transition to an institutional sales model requires the following sequence:

• Month 1-2: Finalize clinical white papers demonstrating the reduction in collision-related costs to satisfy VA procurement requirements.
• Month 3-4: Secure specific HCPCS reimbursement codes to ensure the product is billable by clinicians.
• Month 5-6: Hire two specialized clinical sales representatives with existing VA relationships in high-density veteran regions.
• Month 7-9: Initiate pilot programs in three major VA hospitals to gather longitudinal data on safety outcomes.

Key Constraints

• Clinical Gatekeepers: Success depends entirely on Occupational Therapists. If the installation process adds more than 30 minutes to their workflow, adoption will fail regardless of product efficacy.
• Capital Runway: The current burn rate allows for approximately 12 months of operation. The VA sales cycle often exceeds this, creating a liquidity risk if the first contract is delayed.

Risk-Adjusted Implementation Strategy

To mitigate the long sales cycle of the VA, the company must maintain a secondary revenue stream through direct-to-consumer e-commerce sales. This provides immediate cash flow while the larger institutional deals mature. Contingency planning includes a modular manufacturing approach where components are sourced from multiple vendors to avoid supply chain disruptions that could jeopardize large institutional orders.

Executive Review and BLUF

BLUF

Braze Mobility must pivot from a broad market approach to a disciplined B2B strategy targeting the US Department of Veterans Affairs. The current strategy of chasing multiple segments with limited capital is unsustainable. By securing the VA as a cornerstone client, the company validates its clinical utility and secures the necessary volume to lower unit costs. This focus is the only path to achieving the scale required for a successful Series A funding round within the next 12 months. Immediate action must focus on clinical validation and reimbursement coding.

Dangerous Assumption

The analysis assumes that Occupational Therapists will prioritize safety technology over other competing accessories for a limited per-patient budget. If the VA or private insurers cap the total spend per wheelchair, the Sentina system may be viewed as a luxury rather than a necessity.

Unaddressed Risks

Unconsidered Alternative

The team did not fully evaluate a Software-as-a-Service (SaaS) model. By collecting and anonymizing collision data, Braze could sell safety analytics to insurance companies and facility managers. This would move the company from a hardware-dependent margin to a recurring revenue model with higher valuation multiples.

Verdict

APPROVED FOR LEADERSHIP REVIEW